FEN-1 endonucleases, mixtures and cleavage methods

• US 6,562,611 B1
• Filed: 10/08/1999
• Issued: 05/13/2003
• Est. Priority Date: 11/29/1996
• Status: Expired due to Term

• Current Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Original Assignee: Wave Technologies, Inc.
• Inventors: Lyamichev, Victor I., Kaiser, Michael W., Lyamicheva, Natasha
• Primary Examiner(s): Patterson, Jr., Charles L.
• Application Number:
  US09/308,825
• Time in Patent Office: 1,313 Days
• Field of Search: 435/199, 435/975
• US Class Current: 435/199
• CPC Class Codes: C12N 9/22 Ribonucleases RNAses, DNAses catalytic nucleic acids C12N15/113
• CPC Class Codes: C12Q 1/6823 Release of bound markers
• CPC Class Codes: C12Q 2525/301 Hairpin oligonucleotides
• CPC Class Codes: C12Q 2561/109 Invader technology
• CPC Class Codes: Y10S 435/975 Kit

Abstract

The present invention relates to means for the detection and characterization of nucleic acid sequences, as well as variations in nucleic acid sequences. The present invention also relates to improved cleavage means for the detection and characterization of nucleic acid sequences. Structure-specific nucleases derived from a variety of thermostable organisms are provided. These structure-specific nucleases are used to cleave target-dependent cleavage structures, thereby indicating the presence of specific nucleic acid sequences or specific variations thereof.

Claims

1. A composition comprising an isolated thermostable structure-specific nuclease having an amino acid sequence consisting of SEQ ID NO:

179.

2. The composition of claim 1, wherein said nuclease is encoded by a DNA sequence consisting of SEQ ID NO:

178.

3. A composition comprising a purified FEN-1 endonuclease comprising an Archaeoglobus fulgidus FEN-1 endonuclease.

4. The composition of claim 3, wherein said endonuclease comprises an amino acid sequence comprising SEQ ID NO:

179.

5. The composition of claim 4, wherein said endonuclease is encoded by a DNA sequence comprising SEQ ID NO:

178.

6. A kit comprising the endonuclease of claim 3.

7. A mixture comprising:

i) a first structure-specific nuclease, wherein said first nuclease comprises a purified FEN-1 endonuclease; and

ii) a purified second structure-specific nuclease.

8. The mixture of claim 7, wherein said first structure-specific nuclease comprises an archaeal FEN-1 endonuclease.

9. The mixture of claim 7, wherein said second structure-specific nuclease comprises an archaeal FEN-1 endonuclease.

10. The mixture of claim 7, wherein said first structure-specific nuclease comprises an Archaeoglobus fulgidus FEN-1 endonuclease.

11. The mixture of claim 10, wherein said Archaeoglobus fulgidus FEN-1 endonuclease comprises SEQ ID NO:

179.

12. The mixture of claim 7, wherein said second structure-specific nuclease comprises an Archaeoglobus fulgidus FEN-1 endonuclease.

13. The mixture of claim 12, wherein said Archaeoglobus fulgidus FEN-1 endonuclease comprises SEQ ID NO:

179.

14. The mixture of claim 7, wherein said second structure-specific nuclease comprises a polymerase.

15. The mixture of claim 14, wherein said polymerase comprises a DNA polymerase.

16. The mixture of claim 15, wherein said DNA polymerase comprises a thermostable DNA polymerase.

17. The mixture of claim 7, wherein said second structure-specific nuclease comprises a 5′

nuclease derived from a DNA polymerase altered in amino acid sequence such that it exhibits reduced DNA synthetic activity from that of the wild-type DNA polymerase but retains substantially the same 5′

nuclease activity of the wild-type DNA polymerase.

18. The mixture of claim 17, wherein said 5′

nuclease comprises a thermostable 5′

nuclease.

19. The mixture of claim 7, wherein said second structure-specific nuclease is selected from the group consisting of CLEAVASE BN enzyme, CLEAVASE DA enzyme, CLEAVASE DN enzyme, CLEAVASE DV enzyme, CLEAVASE BN/thrombin enzyme, CLEAVASE TThDN enzyme, Thermus aquaticus DNA polymerase, Thermus thermophilus DNA polymerase, Escherichia coli Exo III, and Saccharomyces cerevisiae Rad1/Rad10 complex.

20. A nucleic acid treatment kit, comprising:

a) a purified Archaeoglobus fulgidus FEN-1 endonuclease; and

b) a solution containing manganese.

21. The kit of claim 26, wherein said Archaeoglobus fulgidus FEN-1 endonuclease comprises SEQ ID NO:

179.

22. The kit of claim 20, further comprising a second structure-specific nuclease.

23. The kit of claim 22, wherein said second structure-specific nuclease comprises a polymerase.

24. The kit of claim 23, wherein said polymerase comprises a DNA polymerase.

25. The kit of claim 24, wherein said DNA polymerase comprises a thermostable DNA polymerase.

26. The kit of claim 22, wherein said second structure-specific nuclease comprises a 5′

nuclease derived from a DNA polymerase altered in amino acid sequence such that it exhibits reduced DNA synthetic activity from that of the wild-type DNA polymerase but retains substantially the same 5′

nuclease activity of the wild-type DNA polymerase.

27. The kit of claim 26, wherein said 5′

nuclease comprises a thermostable 5′

nuclease.

28. The kit of claim 22, wherein a portion of the amino acid sequence of said second structure-specific nuclease is homologous to a portion of an amino acid sequence of a thermostable DNA polymerase derived from a eubacterial thermophile of the genus Thermus.

29. The kit of claim 28, wherein said thermophile is selected from the group consisting of Thermus aquaticus, Thermus flavus, and Thermus thermophilus.

30. The kit of claim 22, wherein said second structure-specific nuclease is selected from the group consisting of CLEAVASE BN enzyme, CLEAVASE DA enzyme, CLEAVASE DN enzyme, CLEAVASE DV enzyme, CLEAVASE BN/thrombin enzyme, CLEAVASE TThDN enzyme, Thermus aquaticus DNA polymerase, Thermus thermophilus DNA polymerase, Escherichia coli Exo III, and Sacccharomyces cerevisiae Rad1/Rad10 complex.

31. The kit of claim 20, further comprising a nucleic acid comprising a folded structure.

32. The kit of claim 31, further comprising one or more reagents for the detection of a cleavage product generated from said nucleic acid.

33. A nucleic acid treatment kit comprising:

a) a composition comprising purified FEN-1 endonuclease;

b) a first oligonucleotide comprising a 5′

portion complementary to a first portion of a target nucleic acid; and

c) a second oligonucleotide comprising;

a 5′

portion complementary to a second portion of said target nucleic acid downstream of and contiguous to said first portion; and

a 3′

portion.

34. The kit of claim 33, wherein said 3′

portion of said second oligonucleotide comprises a 3′

terminal nucleotide not complementary to said target nucleic acid.

35. The kit of claim 33, wherein said 3′

portion of said second oligonucleotide consists of a single nucleotide not complementary to said target nucleic acid.

36. The kit of claim 33, further comprising a solid support.

37. The kit of claim 36, wherein said first oligonucleotide is attached to said solid support.

38. The kit of claim 36, wherein said second oligonucleotide is attached to said solid support.

39. The kit of claim 33, further comprising a buffer solution.

40. The kit of claim 39, wherein said buffer solution comprises a source of divalent cations.

41. The kit of claim 40, wherein said divalent cation comprises Mn²⁺.

42. The kit of claim 33, further comprising a third oligonucleotide complementary to a third portion of said target nucleic acid upstream of said first portion of said first target nucleic acid.

43. The kit of claim 33, further comprising one or more target nucleic acids.

44. The kit of claim 40, wherein said divalent cation comprises Mg²⁺.

45. The kit of claim 33, wherein said purified FEN-1 endonuclease comprises an Archaeoglobus fulgidus FEN-1 endonuclease.

46. The kit of claim 45, wherein said Archaeoglobus fulgidus FEN-1 endonuclease comprises SEQ ID NO:

179.

47. The kit of claim 33, wherein said purified FEN-1 endonuclease comprises an archaeal FEN-1 endonuclease.